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Imprisonment and torture of doctors 
in Bahrain
To the Editor: During the months of February and March 2011, as 
part of the ‘Arab Spring’, protest action and demonstrations took place 
in Manama, capital of the Kingdom of Bahrain. When the authorities 
sought to put down the action, many protesters were injured and 
some died of their injuries. Those who were injured were admitted to 
Salmaniya Medical Complex, the main government hospital in Bahrain. 
That 48 health care workers at the hospital, in keeping with the 
Hippocratic Oath, cared for the protesters as they would for any 
patient was sufficient cause for the arrest, imprisonment and torture 
of these workers.1 The group includes Dr Mahmood Asghar, a 
paediatric surgical colleague known to members of our Association.
After the health care workers had been imprisoned for 6 
months without trial, a military court sentenced them to 15 years’ 
imprisonment. Following an international outcry, this decision was 
set aside. Unfortunately these workers still face trial in a civilian 
court, and while awaiting trial are not able to return to work, or to 
leave the country.
The South African Association of Paediatric Surgeons wishes 
to express its abhorrence of the sanctioning by the government of 
Bahrain of these actions against our colleagues, and urges the South 
African Medical Association and medical colleagues around the 
world to add their voice in condemnation of these actions of the 
government of Bahrain.
Colin Lazarus
President, SA Association of Paediatric Surgeons
colinlaz.paedsurg@gmail.com
1. http://physiciansforhumanrights.org/issues/persecution-of-health-workers/bahrain/
SAMA speaks out about the 
victimisation of doctors in Bahrain
To the Editor: Saunders and London1 correctly highlight the unjust 
punishment of doctors in Bahrain who treated people wounded 
during and after political demonstrations in that country. They 
have been unjustly subjected to military courts and been meted 
out sentences that are viciously disproportionate to their supposed 
infractions. The entire issue is clearly one where a state is abusing 
its authority and violently crushing any hint of rebellion. Similar 
incidents have now been reported in Syria, where doctors are being 
punished for treating so-called opposition rebels. Compounding 
this trend are reports, emanating from several sources, of doctors 
being tortured while in detention and women doctors even being 
threatened with rape while in detention. The issue of state-sponsored 
torture of doctors is reminiscent of our all-too-painful past in 
South Africa. The question correctly posed by the authors is why 
there has been so little outcry from South Africa, with its history 
of doctors subjected to political abuse. Unfortunately, this is where 
our agreement with the authors ends. Several statements have been 
made regarding the alleged inaction by the South African Medical 
Association (SAMA) on this issue. We need to set the record straight 
about SAMA’s response to date, as follows:
1. A SAMA press statement was released in October 2011 that wholly 
condemned the actions by the Bahraini Government.
2. A Medigram in this respect was released in October 2011 to 
members, highlighting the issue.
3. SAMA is a co-signatory on the World Medical Association 
statement condemning the behaviour of the Bahraini Government 
in October 2011.
4. SAMA is a co-signatory to the demand by the group called 
Physician’s for Human Rights to the Bahraini King to stop trials 
and punishment of doctors in Bahrain.
5. In January 2012, the Executive Committee of SAMA discussed 
the issue and agreed to approach the South African Government 
via the Department of International Affairs and Co-operation to 
intervene in this matter, if possible. This approach is ongoing.
SAMA would welcome advice on what further action we could 
take in this regard, but feels that the assertion that we have done 
very little is unfair and without foundation. Furthermore, we call on 
doctors to be aware of such alleged abuses being perpetrated against 
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Legal imperatives for consent for 
children participating in research
To the Editor: Concerning ‘consent for children participating in 
research’, I wish to make readers aware that my previous statement1 
that s71 of the National Health Act of 20032 was not in force, is no 
longer the case. A statement from the National Health Research 
Ethics Council (NHREC) Chairperson Professor D du Toit informs 
all stakeholders that s71 of the National Health Act was proclaimed 
with effect from 1 March 2012.3 Professor du Toit makes the point 
that s71 introduces new requirements for health research, ‘including 
(1) written consent (2) consent from a parent or guardian for research 
with children (3) “therapeutic research” should be in a child’s best 
interest and (4) consent from the Minister must be obtained for 
“non-therapeutic research” with children’. He further elaborates 
that ‘regulations are yet to be issued providing greater detail and 
operational guidance to RECs, particularly for the latter requirement’. 
I deduce that the Minister will probably soon delegate the consent 
for non-therapeutic research on children to an appropriately defined 
body such as the NHREC. The ethical imperatives4 that I raised in my 
previous letter are now legal imperatives in our country.
Shan Naidoo
Department: Community Health
Member of the HREC (Medical)
Faculty of Health Sciences
University of the Witwatersrand
Johannesburg
shan.naidoo@wits.ac.za
1. Naidoo S. Consent for children participating in research. S Afr Med J 2012;102(3):110.
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3. Statement from the Council on Proclamation of s71 of National Health Act. Pretoria: National Health 
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Stem cell therapy and amyotrophic 
lateral sclerosis
To the Editor: We have been made aware of several patients with 
neurological diseases attending stem cell therapy centres, and in 
particular individuals with amyotrophic lateral sclerosis (ALS). The 
opening of stem cell clinics in South Africa has led to an increased 
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number of patients pursuing this therapy at great financial cost and 
with high expectations. Regarding this technology, we would like to 
emphasise the following:
1. There is a complete absence of sound clinical evidence for the 
efficacy of stem cell therapy for ALS and neurodegenerative 
diseases in general. No randomised controlled studies or even 
open-label studies with long-term follow-up exist. Furthermore, a 
prospective case series in the Netherlands showed no benefit from 
treatment with olfactory ensheathing cells in patients with ALS.1
2. Long-term safety data on the use of stem cell therapy in neurological 
disorders are lacking.
3. Currently, the main utility for stem cell technology in neurological 
disorders is the ability to offer human in vitro models for 
understanding disease mechanisms and facilitating drug discovery. 
Although the potential for cell-based therapy exists, current claims 
of efficacy in ALS and other neurodegenerative disorders are 
premature and unsubstantiated.
We have strong scientific, ethical and economic objections to 
clinics offering stem cell therapy on a commercial basis, as well as 
medical practitioners recommending (or not advising against) this 
modality for neurological disorders. Patients with incurable diseases 
such as ALS are desperate and emotionally vulnerable to the claims 
of institutions allegedly being able to heal a number of diseases that 
modern medicine is unable to. Although we respect their autonomy 
and right to self-determination, patients are seldom equipped to 
assess the evidence for or against different treatment modalities, 
and are therefore reliant on medical professionals in decision-
making. Moreover, regulations guiding stem cell research and therapy 
are sorely lacking in South Africa.2 It is therefore the healthcare 
professional’s moral duty to present patients and their families with 
relevant information in an understandable manner. In the case of 
stem cell therapy, this involves a thorough discussion about the 
absence of scientific evidence and the likelihood that substantial 
sums will be paid by patients for no discernible benefit. Failing to do 
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Hydatid cysts of the breast and parotid 
gland
To the Editor: We report 2 interesting cases of hydatid cysts in 
unusual sites: in the breast and the deep lobe of the parotid gland.
Hydatid cysts are an infectious disease caused by the larval stage 
of the cestode Echinococcus. Humans are mostly affected by E. 
granulosus as incidental intermediate hosts. The liver (70%) and lungs 
(25%) are most commonly affected, with the spleen, heart, kidneys, 
bone, nervous system and soft tissue less frequently affected.1 Even 
in endemic areas, hydatid disease of the head, neck and breast is 
extremely rare. The incidence of hydatid cyst in the breast has been 
reported as 0.27%.2 No parotid gland incidence figures are available.
A 24-year-old woman from Van Wyksvlei was referred to the 
surgical clinic with a lump in the superolateral quadrant of the left 
breast. Fine-needle aspiration was performed at a local clinic before 
referral to the surgical clinic; parasitic hooklets were observed, 
diagnosing an Echinococcus cyst. Chest X-ray (CXR) and abdominal 
sonar showed no other cysts. Pre-operative albendazole was 
administered and the cyst was removed by excision biopsy (Fig. 1). 
There were no postoperative complications.
In the second case, an HIV-negative 20-year-old man from Britstown 
was referred with a cystic mass in the right parotid area. The cyst, 
present for about 2 years, had fluctuated in size. It appeared superficial 
on examination. In the absence of a radiologist at the facility, informed 
consent was obtained for excision of the cyst with or without superficial 
parotidectomy. On excision, the cyst appeared to extend into the deep 
lobe of the parotid gland. Superficial parotidectomy and excision of 
the cyst was performed without injury to the facial nerve. Histology 
confirmed normal superficial parotid tissue and an Echinococcus cyst. 
CXR and abdominal sonar showed no other cysts. The patient was 
given albendazole and discharged; he returned once for follow-up.
Hydatid disease is a prevalent parasitic infection in sheep-rearing 
areas such as the Northern Cape. Although hydatid cysts in the head, 
neck and breast are extremely rare, Echinococcus infection should be 
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Fig.1. Hydatid cyst excised from the breast.
Correction
We regret that an error occurred in the March 2012 issue of SAMJ. The citation in the abstract of the article ‘Dyer SJ, Kruger TF. Assisted 
reproductive technology in South Africa: First results generated from the South African Register of Assisted Reproductive Techniques’ 
should have read ‘S Afr Med J 2012;102:167-170.’ The online version was corrected on 11 May 2012.
